FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.19
+2.64% today
Updated 2026-04-30
Market cap
$470.46M
P/E ratio
—
P/S ratio
1.46x
EPS (TTM)
$-1.97
Dividend yield
—
52W range
$13 – $31
Volume
0.7M
Fulgent Genetics Inc (FLGT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-18.80%
Operating margin
-41.20%
ROE
-5.51%
ROA
-4.58%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $1.28M | $-4.28M | 26.76% | -77.46% | -335.13% |
| 2015 | $9.58M | $-8.31M | 47.07% | -52.34% | -86.82% |
| 2016 | $18.28M | $-5.39M | 63.22% | 5.03% | -29.48% |
| 2017 | $18.73M | $-2.66M | 54.35% | -18.15% | -14.21% |
| 2018 | $21.36M | $-4.49M | 49.94% | -23.68% | -21.02% |
| 2019 | $32.53M | $366000.00 | 56.63% | -1.32% | 1.13% |
| 2020 | $421.71M | $214.31M | 78.70% | 68.80% | 50.82% |
| 2021 | $992.58M | $104.34M | 78.29% | 10.51% | 10.51% |
| 2022 | $618.97M | $143.40M | 59.28% | 28.84% | 23.17% |
| 2023 | $289.21M | $-167.82M | 36.12% | -67.61% | -58.03% |
| 2024 | $283.47M | $-42.71M | 37.82% | -26.08% | -15.07% |
| 2025 | $322.67M | $-60.51M | 40.56% | -28.23% | -18.75% |